Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
A meta-analysis has shown that third generation oral
contraceptives carry a 1.7-fold higher risk of venous thromboembolism than second generation pills. Kemmeren et al (p 131) pooled the results of studies that collected data up to October 1995, when four
studies highlighted the possible risk of third generation oral
contraceptives (containing desogestrel or gestodene). The increase in
risk was greatest in first time users and could not be accounted for by
biased selection of study groups or in other flaws in design and
analysis of the studies.